Benckert Martin, Lilja Mikael, Söderberg Stefan, Eliasson Mats
Department of Public Health and Clinical Medicine, Sunderby Research Unit, Umeå University, Umeå, Sweden.
Department of Public Health and Clinical Medicine, Östersund Research Unit, Umeå University, Umeå, Sweden.
BMC Obes. 2015 Feb 22;2:7. doi: 10.1186/s40608-015-0040-x. eCollection 2015.
The incidence of CVD is decreasing in spite of increasing BMI in the population. We examined trends in metabolic health among overweight and obese individuals and the influence of lifestyle and socioeconomic status. Six cross sectional population surveys in the Northern Sweden MONICA Study between 1986 and 2009. 8 874 subjects 25 to 64 years participated (74% participation rate). Metabolic health was defined as a total cholesterol level below 5.0 mmol/l, blood pressure below 140/90 mmHg and not having diabetes. In 2009 the age span 25 to 74 years was studied.
The prevalence of metabolic health among obese subjects increased by 7.9 % per year (95% confidence interval 5.4; 10.5), reaching 21.0% in 2009. The corresponding figures for overweight subjects were 5.9% per year (4.6; 7.3), reaching 18% in 2009, whereas for the normal-weight subjects, the increase was 6.2% per year (5.3; 7.2), reaching 39% in 2009. The prevalence of metabolic health among subjects with abdominal obesity increased by 5.8% (4.6; 7.0) per year, reaching 17.3% in 2009. Among those with no abdominal obesity the increase was 6.2% (5.2; 7.1), reaching 38% in 2009 (p = <0.001 for all groups). Only among non-obese men and obese women did the increase continue between 2004 and 2009. In the other groups a slight decline or levelling off was noted. In 2009 women had a 27% higher prevalence of metabolic health than men. The prevalence of metabolic health among the obese was 19.8% which declined to 15.8% if subjects treated for hypertension or hypercholesterolemia were classified as not healthy. Overweight and obese subjects were less often metabolically healthy (odds ratio 0.54 and 0.59 respectively) compared with normal-weight subjects, independent of sex and age as were subjects with abdominal obesity (odds ratio 0.52). Adjustments for smoking, physical activity and education level did not influence any estimates.
This report shows a large increase in prevalence of metabolic health from 1986 to 2009 for all anthropometric categories. Metabolic health remains considerably less prevalent among overweight and obese subjects than among those with normal weight.
尽管人群体重指数(BMI)不断上升,但心血管疾病(CVD)的发病率却在下降。我们研究了超重和肥胖个体的代谢健康趋势以及生活方式和社会经济地位的影响。这是瑞典北部莫尼卡研究在1986年至2009年期间进行的六项横断面人群调查。共有8874名年龄在25至64岁之间的受试者参与(参与率为74%)。代谢健康的定义为总胆固醇水平低于5.0 mmol/l、血压低于140/90 mmHg且未患糖尿病。2009年对年龄跨度为25至74岁的人群进行了研究。
肥胖受试者中代谢健康的患病率每年增加7.9%(95%置信区间为5.4;10.5),到2009年达到21.0%。超重受试者的相应数字为每年5.9%(4.6;7.3),2009年达到18%,而正常体重受试者的增加幅度为每年6.2%(5.3;7.2),2009年达到39%。腹部肥胖受试者中代谢健康的患病率每年增加5.8%(4.6;7.0),2009年达到17.3%。在没有腹部肥胖的受试者中,增加幅度为6.2%(5.2;7.1),2009年达到38%(所有组的p值均<0.001)。只有非肥胖男性和肥胖女性在2004年至2009年期间患病率持续上升。在其他组中,出现了轻微下降或趋于平稳的情况。2009年,女性的代谢健康患病率比男性高27%。肥胖者中代谢健康的患病率为19.8%,如果将接受高血压或高胆固醇血症治疗的受试者归类为不健康,则该患病率降至15.8%。与正常体重受试者相比,超重和肥胖受试者代谢健康的情况较少见(优势比分别为0.54和0.59),腹部肥胖受试者也是如此(优势比为0.52),且不受性别和年龄影响。对吸烟、身体活动和教育水平进行调整后,不影响任何估计值。
本报告显示,从1986年到2009年,所有人体测量类别中代谢健康的患病率都大幅上升。超重和肥胖受试者的代谢健康患病率仍远低于正常体重者。